Daniel Shevrin to Prospective Studies
This is a "connection" page, showing publications Daniel Shevrin has written about Prospective Studies.
Connection Strength
0.152
-
A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2026 Aug; 24(5):102570.
Score: 0.126
-
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1549-1559.
Score: 0.024
-
Treatment of cancer-associated hypercalcemia with cisplatin. Arch Intern Med. 1987 Feb; 147(2):329-32.
Score: 0.002